未登录

M

Miao Xian

center for translational research in hematological malignancies

H指数:11

被引数:546

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Activating RARβ to overcome immunomodulatory drug resistance in t(4;14) human myeloma

通过激活RARβ克服t(4;14)人类骨髓瘤的免疫调节药物耐药性

IF13.4

2026-07-300

OA

T cells engineered against Dickkopf-1-A2 complex can be used to treat HLA-A2+ solid and hematologic cancers

针对Dickkopf-1-A2复合物的工程化T细胞可用于治疗HLA-A2阳性的实体瘤和血液系统癌症

Nature Communications

IF15.7

2026-02-160

OAAI

A Study on Real-Time Condition Monitoring Methods for Wind Tunnels Based on POD and BPNN

基于POD和BPNN的风洞实时状态监测方法研究

IF2.2

2025-11-101

OAAI

The HER2 inhibitor TAK165 Sensitizes Human Acute Myeloid Leukemia Cells to Retinoic Acid-Induced Myeloid Differentiation by activating MEK/ERK mediated RARα/STAT1 axis (vol 6, 24589, 2016)

SCIENTIFIC REPORTS

IF3.9

2024-10-070

OAAI

Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis

NATURE COMMUNICATIONS

IF15.7

2024-07-091

OAAI

Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Targeting LILRB1 to sensitize human myeloma to ferroptosis through disrupting cholesterol homeostasis

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Lipid peroxidation of immune cells in cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-01-088

OAAI

A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2022-05-073

OAAI

IL-9/STAT3/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2022-04-0150

OAAI

Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells (vol 8, pg 1617, 2017)

STEM CELL REPORTS

IF5.1

2020-05-011

OAAI

Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells

STEM CELL REPORTS

IF5.1

2017-06-0150

OAAI

Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2017-05-3140

OAAI

The HER2 inhibitor TAK165 Sensitizes Human Acute Myeloid Leukemia Cells to Retinoic Acid-Induced Myeloid Differentiation by activating MEK/ERK mediated RARα/STAT1 axis

SCIENTIFIC REPORTS

IF3.9

2016-04-1417

OAAI